Abstract

Mesoporous silica nanoparticles (MSN) have been attracted in the field of biomedicine due to their versatile properties as a drug nanocarrier. In this research, MSN and thiol modified MSN (mMSN) were synthesized to be the drug nanocarriers, by the sol-gel technique for the efficient delivering doxorubicin hydrochloride (DOX). These carriers were characterized by Transmission Electron Microscopy (TEM), Field Emission Scanning Electron Microscopy (FESEM), SA3100 analyzer (Brunauer-Emmett-Teller), Zetasizer and Fourier transform infrared spectroscopy (FTIR). FESEM observation revealed that these particles have uniform sizes and the zeta potential analysis confirmed the existence of surface charge and stability of the particles. Brunauer-Emmett-Teller showed that MSN and mMSN are characteristic type IV N-2 adsorption/desorption patterns. The in vitro drug release profile studies have profound that the drug-loaded carriers were pH dependent and the drug-loaded mMSN (DOX@mMSN) displayed a faster drug release at the acidic pH with tumor cells than the pH with normal cells. Cell cycle arrest and ROS generation were analyzed by Fluorescence-activated cell sorting. Assay on the cytotoxicity against the HeLa cells showed a better antitumor effect with DOX@mMSN compared to DOX@MSN. This study attested that pH -responsive thiol modified drug nanocarrier can have the potential cancer therapy. (C) 2018 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.